Skip to Main Content

Patient Survival Outcomes

The five year relative survival rate is an estimate of the proportion of patients who would be expected to survive the effects of their cancer at least five years after their initial cancer diagnosis if the only possible cause of death for the patient was the cancer they were diagnosed with.

The Surveillance, Epidemiology, and End Results (SEER) Program provides information on cancer statistics in an effort to reduce the cancer burden among the U.S. population. SEER is supported by the Surveillance Research Program (SRP) in NCI's Division of Cancer Control and Population Sciences (DCCPS).

All incidence and mortality rates in these reports are age-adjusted to the 2000 US standard population.

Acute Lymphocytic Leukemia

Acute Myeloid Leukemia

Acute Myeloid Leukemia

Acute Myeloid Leukemia

Bladder

Bladder

Brain/Central Nervous System

Brain/Central Nervous System

Cervix Uteri

Cervix Uteri

Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

Chronic Myeloid Leukemia

Chronic Myeloid Leukemia

Colon and Rectum

Colon and Rectum

Corpus Uteri

Corpus Uteri

Esophagus

Esophagus

Female Breast

Female Breast

Hodgkin Lymphoma

Hodgkin Lymphoma

Kidney Renal Pelvis

Kidney Renal Pelvis

Larynx

Larynx

Leukemia

Leukemia

Liver Intrahepatic Bile Duct

Liver Intrahepatic Bile Duct

Lung and Bronchus

Lung and Bronchus

Malignant Mesothelioma

Malignant Mesothelioma

Melanoma Skin

Melanoma Skin

Myeloma

Myeloma

Non Hodgkin Lymphoma

Non Hodgkin Lymphoma

Oral Cavity Pharynx

Oral Cavity Pharynx

Ovary

Ovary

Pancreas

Pancreas

Prostate

Prostate

Rectum

Rectum

Stomach

Stomach

Testis

Testis

Thyroid

Thyroid